Jike Wang

Jike Wang

Auto-generated profile, based on publicly available information

Jike Wang

Zhejiang University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2025 in Science Advances
Verified
Journal Article
Open access
JWJike Wang
Jike Wang
JFJianwen Feng
Jianwen Feng
YKYu Kang
Yu Kang
PPPeichen Pan
Peichen Pan
JGJingxuan Ge
Jingxuan Ge
THTingjun Hou
Tingjun Hou
Large language models (LLMs) have shown remarkable advancements in chemistry and biomedical research, acting as versatile foundation models for various tasks. We introduce AMP-Designer, an LLM-based approach, for swiftly designing antimicrobial peptides (AMPs) with desired properties. Within 11 days, AMP-Designer achieved the de novo design of 18 AMPs with broad-spectrum activity against Gram-negative bacteria. In vitro validation revealed a 94.4% success rate, with two candidates demonstrating exceptional antibacterial efficacy, minimal hemotoxicity, stability in human plasma, and low potential to induce resistance, as evidenced by significant bacterial load reduction in murine lung infection experiments. The entire process, from design to validation, concluded in 48 days. AMP-Designer excels in creating AMPs targeting specific strains despite limited data availability, with a top candidate displaying a minimum inhibitory concentration of 2.0 micrograms per milliliter against Propionibacterium acnes . Integrating advanced machine learning techniques, AMP-Designer demonstrates remarkable efficiency, paving the way for innovative solutions to antibiotic resistance.

17 September 2025 in Chemical Reviews
Verified
Journal Article
Closed access
OZOdin Zhang
Odin Zhang
HLHaitao Lin
Haitao Lin
XZXujun Zhang
Xujun Zhang
XWXiaorui Wang
Xiaorui Wang
ZWZhenxing Wu
Zhenxing Wu
THTingjun Hou
Tingjun Hou

12 January 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
HZHaotian Zhang
Haotian Zhang
SLShengming Li
Shengming Li
JZJintu Zhang
Jintu Zhang
ZWZhe Wang
Zhe Wang
JWJike Wang
Jike Wang
THTingjun Hou
Tingjun Hou
In this paper, we developed a novel conformation generation model, termed SDEGen, learning how a molecule evolves in a stochastic dynamics system starting from noise and eventually relaxing to the conformation that falls into low energy minima.

19 March 2024 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
DJDejun Jiang
Dejun Jiang
HDHongyan Du
Hongyan Du
HZHuifeng Zhao
Huifeng Zhao
YDYafeng Deng
Yafeng Deng
ZWZhenxing Wu
Zhenxing Wu
CHChang-Yu Hsieh
Chang-Yu Hsieh
Ribonucleic acid (RNA)–ligand interactions play a pivotal role in a wide spectrum of biological processes, ranging from protein biosynthesis to cellular reproduction. This recognition has prompted the broader acceptance of RNA as a viable candidate for drug targets. Delving into the atomic-scale understanding of RNA–ligand interactions holds paramount importance in unraveling intricate molecular mechanisms and further contributing to RNA-based drug discovery. Computational approaches, particularly molecular docking, offer an efficient way of predicting the interactions between RNA and small molecules. However, the accuracy and reliability of these predictions heavily depend on the performance of scoring functions (SFs). In contrast to the majority of SFs used in RNA–ligand docking, the end-point binding free energy calculation methods, such as molecular mechanics/generalized Born surface area (MM/GBSA) and molecular mechanics/Poisson Boltzmann surface area (MM/PBSA), stand as theoretically more rigorous approaches. Yet, the evaluation of their effectiveness in predicting both binding affinities and binding poses within RNA–ligand systems remains unexplored. This study first reported the performance of MM/PBSA and MM/GBSA with diverse solvation models, interior dielectric constants (εin) and force fields in the context of binding affinity prediction for 29 RNA–ligand complexes. MM/GBSA is based on short (5 ns) molecular dynamics (MD) simulations in an explicit solvent with the YIL force field; the GBGBn2 model with higher interior dielectric constant (εin = 12, 16 or 20) yields the best correlation (Rp = −0.513), which outperforms the best correlation (Rp = −0.317, rDock) offered by various docking programs. Then, the efficacy of MM/GBSA in identifying the near-native binding poses from the decoys was assessed based on 56 RNA–ligand complexes. However, it is evident that MM/GBSA has limitations in accurately predicting binding poses for RNA–ligand systems, particularly compared with notably proficient docking programs like rDock and PLANTS. The best top-1 success rate achieved by MM/GBSA rescoring is 39.3%, which falls below the best results given by docking programs (50%, PLNATS). This study represents the first evaluation of MM/PBSA and MM/GBSA for RNA–ligand systems and is expected to provide valuable insights into their successful application to RNA targets.

23 May 2024 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
RJRuofan Jin
Ruofan Jin
QYQing Ye
Qing Ye
JWJike Wang
Jike Wang
ZCZheng Cao
Zheng Cao
DJDe-Jun Jiang
De-Jun Jiang
THTingjun Hou
Tingjun Hou
The optimization of therapeutic antibodies through traditional techniques, such as candidate screening via hybridoma or phage display, is resource-intensive and time-consuming. In recent years, computational and artificial intelligence-based methods have been actively developed to accelerate and improve the development of therapeutic antibodies. In this study, we developed an end-to-end sequence-based deep learning model, termed AttABseq, for the predictions of the antigen–antibody binding affinity changes connected with antibody mutations. AttABseq is a highly efficient and generic attention-based model by utilizing diverse antigen–antibody complex sequences as the input to predict the binding affinity changes of residue mutations. The assessment on the three benchmark datasets illustrates that AttABseq is 120% more accurate than other sequence-based models in terms of the Pearson correlation coefficient between the predicted and experimental binding affinity changes. Moreover, AttABseq also either outperforms or competes favorably with the structure-based approaches. Furthermore, AttABseq consistently demonstrates robust predictive capabilities across a diverse array of conditions, underscoring its remarkable capacity for generalization across a wide spectrum of antigen-antibody complexes. It imposes no constraints on the quantity of altered residues, rendering it particularly applicable in scenarios where crystallographic structures remain unavailable. The attention-based interpretability analysis indicates that the causal effects of point mutations on antibody–antigen binding affinity changes can be visualized at the residue level, which might assist automated antibody sequence optimization. We believe that AttABseq provides a fiercely competitive answer to therapeutic antibody optimization.

19 January 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
DJDejun Jiang
Dejun Jiang
ZYZhaofeng Ye
Zhaofeng Ye
CHChang-Yu Hsieh
Chang-Yu Hsieh
ZYZhiyi Yang
Zhiyi Yang
XZXujun Zhang
Xujun Zhang
THTingjun Hou
Tingjun Hou
Metalloproteins play essential roles in various biological processes ranging from reaction catalysis to free radical scavenging, and they are also pertinent to numerous pathologies including cancer, HIV infection,and inflammation.